Dyadic International Inc (DYAI)
1.45
-0.04
(-2.68%)
USD |
NASDAQ |
Apr 26, 16:00
1.45
0.00 (0.00%)
After-Hours: 20:00
Dyadic International Cash from Financing (TTM): 0.00 for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.1415M |
June 30, 2023 | 0.5012M |
March 31, 2023 | 0.5012M |
December 31, 2022 | 0.5436M |
September 30, 2022 | 0.6466M |
June 30, 2022 | 0.2863M |
March 31, 2022 | 1.157M |
December 31, 2021 | 1.230M |
September 30, 2021 | 1.010M |
June 30, 2021 | 1.011M |
March 31, 2021 | 0.1963M |
December 31, 2020 | 0.2555M |
September 30, 2020 | 0.4524M |
June 30, 2020 | 0.6318M |
March 31, 2020 | 0.7252M |
December 31, 2019 | 0.5502M |
September 30, 2019 | 0.3286M |
June 30, 2019 | -1.776M |
March 31, 2019 | -1.925M |
December 31, 2018 | -2.300M |
September 30, 2018 | -2.827M |
June 30, 2018 | -0.9125M |
March 31, 2018 | -0.911M |
December 31, 2017 | -6.222M |
Date | Value |
---|---|
September 30, 2017 | -9.283M |
June 30, 2017 | -12.96M |
March 31, 2017 | -14.95M |
December 31, 2016 | -13.12M |
September 30, 2016 | -11.51M |
June 30, 2016 | -7.811M |
March 31, 2016 | -5.807M |
December 31, 2015 | 0.0739M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | 0.1621M |
December 31, 2013 | 0.2206M |
September 30, 2013 | 0.2159M |
June 30, 2013 | 0.137M |
March 31, 2013 | 0.0956M |
September 30, 2012 | 12.84M |
June 30, 2012 | 13.18M |
March 31, 2012 | 19.02M |
December 31, 2006 | 18.99M |
September 30, 2006 | 6.190M |
June 30, 2006 | 5.846M |
March 31, 2006 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.776M
Minimum
Jun 2019
1.230M
Maximum
Dec 2021
0.4417M
Average
0.5012M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
AIM ImmunoTech Inc | 0.485M |
Perspective Therapeutics Inc | 0.785M |
Protalix BioTherapeutics Inc | 24.67M |
Electromed Inc | -0.128M |
Armata Pharmaceuticals Inc | 53.99M |